Jean Ho-Rath v. Corning Incorporated Yendee Ho-Rath v. Rhode Island Hospital

CourtSupreme Court of Rhode Island
DecidedMay 27, 2022
Docket20-227, 228
StatusPublished

This text of Jean Ho-Rath v. Corning Incorporated Yendee Ho-Rath v. Rhode Island Hospital (Jean Ho-Rath v. Corning Incorporated Yendee Ho-Rath v. Rhode Island Hospital) is published on Counsel Stack Legal Research, covering Supreme Court of Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jean Ho-Rath v. Corning Incorporated Yendee Ho-Rath v. Rhode Island Hospital, (R.I. 2022).

Opinion

May 27, 2022

Supreme Court

Jean Ho-Rath et al. :

v. : No. 2020-227-Appeal. (PC 10-4186) Corning Incorporated et al. :

Yendee Ho-Rath et al. :

v. : No. 2020-228-Appeal. (PC 17-125) Rhode Island Hospital et al. :

NOTICE: This opinion is subject to formal revision before publication in the Rhode Island Reporter. Readers are requested to notify the Opinion Analyst, Supreme Court of Rhode Island, 250 Benefit Street, Providence, Rhode Island 02903, at Telephone 222-3258 or Email opinionanalyst@courts.ri.gov of any typographical or other formal errors in order that corrections may be made before the opinion is published. Supreme Court

v. : No. 2020-227-Appeal. (PC 10-4186) Corning Incorporated et al. :

v. : No. 2020-228-Appeal. (PC 17-125) Rhode Island Hospital et al. :

Present: Suttell, C.J., Robinson, and Lynch Prata, JJ.

OPINION

Justice Lynch Prata, for the Court. In these consolidated appeals the

plaintiffs, Jean Ho-Rath, Bunsan Ho-Rath, and Yendee Ho-Rath (collectively

plaintiffs),1 appeal from judgments of the Superior Court entered in favor of the

defendants, Corning Incorporated (Corning), Quest Diagnostics, LLC (Quest),

Rhode Island Hospital (RIH), Women & Infants Hospital of Rhode Island (WIH),

1 The plaintiffs’ first names will be used throughout this opinion to avoid confusion. No disrespect is intended.

-1- Marsha Sverdrup, M.S., and Jami A. Star, M.D. (collectively defendants).2 The

plaintiffs assert that the hearing justice erred in finding that the defendants owed

them no duty of care. For the reasons set forth herein, we affirm the judgments of

the Superior Court.

Facts and Travel

This Court has twice before been presented with questions relative to the

statute of limitations applicable to plaintiffs’ claims. See Ho-Rath v. Rhode Island

Hospital, 115 A.3d 938, 946, 950 (R.I. 2015) (Ho-Rath II) (holding that a minor

plaintiff in a medical malpractice action has two options to comply with the

applicable statute of limitations: (1) suit may be filed on the minor’s behalf within

three years of the occurrence or reasonable discovery of the alleged malpractice; or

(2) the minor may file suit on their own behalf upon reaching the age of majority,

and further holding that a parent’s claim for loss of consortium in a medical

malpractice action is tolled in tandem with the minor’s claim from which it is

derived); Ho-Rath v. Rhode Island Hospital, 89 A.3d 806, 812 (R.I. 2014) (Ho-Rath

I) (holding that claims asserted by plaintiffs against laboratories sounded in ordinary

negligence and were governed by the statute of limitations set forth in G.L. 1956

2 We recognize that there are various and differing claims asserted against each individual defendant. Some of these claims sound in medical negligence, while others sound in ordinary negligence. Unless this distinction implicates the analysis of the issues before this Court, we shall refer to the defendants collectively for ease of reference.

-2- § 9-1-19). Although many of the facts in this case are set forth in those opinions,

because the present appeals involve a substantive challenge to the viability of

plaintiffs’ claims, we shall set forth the facts and procedural history in toto.

Jean and Bunsan are the parents of Yendee, who was born January 9, 1998, at

WIH. In the months and years following her birth, Yendee underwent genetic testing

for alpha thalassemia, a genetic blood disorder that impairs the production of

hemoglobin and can lead to “severe and fatal anemia.” Stedman’s Medical

Dictionary 1969 (28th ed. 2006). According to Jean, by October 2003 Yendee was

“very ill[,]” and she was ultimately confirmed to have Hemoglobin H disease.

Yendee was Jean and Bunsan’s second child. During her first pregnancy, Jean

presented to WIH for prenatal care and, due to her Southeast Asian descent, she was

offered genetic counseling and testing “to possibly rule out carrier status of beta

thalassemia.” The results of two hemoglobin electrophoreses performed by MetPath

Teterboro Laboratory (MetPath)3 in February and May 1993 indicated that Jean had

3 According to interrogatory answers submitted by Quest, MetPath was acquired by Corning in 1982 and operated as a subsidiary corporation through 1996. Thereafter, MetPath was spun off into Quest, a named defendant in this case.

-3- a normal pattern.4 Sanhkdee, Jean and Bunsan’s first child, was born on November

15, 1993, and, as part of a clinical project, WIH sent both Sanhkdee’s and Jean’s

blood to RIH for hemoglobin electrophoresis.5 The results from RIH showed that

both Jean and Sanhkdee tested positive for the presence of alpha thalassemia.

Thereafter, Bunsan’s blood was sent to MetPath for hemoglobin electrophoresis; on

December 28, 1993, it was reported that Bunsan had a normal pattern.

While pregnant with Yendee, Jean again presented to WIH for prenatal care

and genetic counseling. A counselor and a doctor from WIH’s Prenatal Diagnosis

Center prepared a report on July 29, 1997, detailing the presence of alpha

thalassemia that became apparent after Sanhkdee’s birth. The report opined, based

on an evaluation performed by B.E. Barker, Ph.D. at RIH’s Special Hematology

Laboratory, that Sanhkdee “most likely has a two gene alpha thalassemia deletion as

does Ms. Ho-Rath and that Mr. Rath most likely does not carry a two gene alpha

thalassemia deletion, however a single gene alpha thalassemia mutation may be

4 Jean testified at her deposition on November 21, 2017, that the results of the February 1993 electrophoresis revealed that she had “a Thalassemia Trait and the genetic counselor want[ed] to find out if [her] husband has the same * * * Trait.” She recalled Bunsan being tested in 1993 but could not recall where he had that test. She stated that a genetic counselor at WIH told her that Bunsan’s blood work results were normal. There is no other evidence in the record of the results of that test. Moreover, the results of the February and May 1993 electrophoreses performed on Jean showed she had a normal pattern. 5 Sanhkdee is not a party to these proceedings.

-4- present.” (Emphasis omitted.) The report stated that the health-care professionals

from WIH discussed alpha thalassemia with Jean “in full[,]” and counseled her that

if Bunsan carries “a single gene mutation there would be a 25% chance for this fetus

to have hemoglobin H disease.”

When Yendee became seriously ill in 2003, her blood sample was tested by

RIH’s Special Hematology Laboratory and it was confirmed that she had

“Hemoglobin Constant Spring trait and a two gene deletion alpha thalassemia trait

is present.” Approximately sixteen months later, Bunsan was tested by RIH’s

laboratory; on May 6, 2005, Dr. Barker reported that Bunsan “has been shown to

possess Hb Constant Spring trait.”

Jean and Bunsan first filed suit individually and on behalf of Yendee on July

12, 2010. The complaint alleged that numerous defendants, many of whom are not

parties to the present appeal, were negligent in failing to properly diagnose, test,

treat, and care for plaintiffs and that, as a result of the alleged negligence, Yendee

suffered injuries and Jean and Bunsan suffered loss of consortium. A Superior Court

justice entered judgments in favor of Corning, Quest, and WIH in August 2011

because she found that various claims advanced by plaintiffs were barred by the

applicable statute of limitations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

D.D. v. Idant Laboratories
374 F. App'x 319 (Third Circuit, 2010)
Diane Berard v. HCP, Inc.
64 A.3d 1215 (Supreme Court of Rhode Island, 2013)
Roland DeMaio v. Raymond A. Ciccone
59 A.3d 125 (Supreme Court of Rhode Island, 2013)
Bruggeman Ex Rel. Bruggeman v. Schimke
718 P.2d 635 (Supreme Court of Kansas, 1986)
Greco v. United States
893 P.2d 345 (Nevada Supreme Court, 1995)
Willis Ex Rel. Willis v. Wu
607 S.E.2d 63 (Supreme Court of South Carolina, 2004)
WALKER BY PIZANO v. Mart
790 P.2d 735 (Arizona Supreme Court, 1990)
Schenck v. Roger Williams General Hospital
382 A.2d 514 (Supreme Court of Rhode Island, 1977)
Hydro-Manufacturing, Inc. v. Kayser-Roth Corp.
640 A.2d 950 (Supreme Court of Rhode Island, 1994)
Elliott v. Brown
361 So. 2d 546 (Supreme Court of Alabama, 1978)
Desjarlais v. USAA Insurance Co.
824 A.2d 1272 (Supreme Court of Rhode Island, 2003)
Flanagan v. Wesselhoeft
712 A.2d 365 (Supreme Court of Rhode Island, 1998)
Banks v. Bowen's Landing Corp.
522 A.2d 1222 (Supreme Court of Rhode Island, 1987)
Siemieniec v. Lutheran General Hospital
512 N.E.2d 691 (Illinois Supreme Court, 1987)
Ouch v. Khea
963 A.2d 630 (Supreme Court of Rhode Island, 2009)
Gliottone v. Ethier
870 A.2d 1022 (Supreme Court of Rhode Island, 2005)
Santana v. Rainbow Cleaners, Inc.
969 A.2d 653 (Supreme Court of Rhode Island, 2009)
Donovan v. Idant Laboratories
625 F. Supp. 2d 256 (E.D. Pennsylvania, 2009)
Emerson v. Magendantz
689 A.2d 409 (Supreme Court of Rhode Island, 1997)
Wilkinson v. Vesey
295 A.2d 676 (Supreme Court of Rhode Island, 1972)

Cite This Page — Counsel Stack

Bluebook (online)
Jean Ho-Rath v. Corning Incorporated Yendee Ho-Rath v. Rhode Island Hospital, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jean-ho-rath-v-corning-incorporated-yendee-ho-rath-v-rhode-island-ri-2022.